This class of medications contains the popular semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)
Scalp Rejuvenation and Hair Growth Stimulation by GHK-Cu
AMPK and SIRT1: a long-standing partnership
By 12 months, they were: 40 percent more likely to develop nonscarring hair loss 64 percent more likely to develop pattern thinning 76 percent more likely to experience stress-related shedding, a temporary increase in hair shedding that often shows up a few months after a physical stressor such as illness, surgery, childbirth, or rapid weight loss The study did not find an increased risk of alopecia areata, an autoimmune form of hair loss